The Future Of Food: Beyond Legacy Brands
Berkshire Hathaway's multi-billion dollar writedown of its Kraft Heinz stake highlights the struggles of legacy food brands. This creates an opportunity to invest in innovative food companies that are better aligned with modern consumer preferences for healthier and more natural products.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Berkshire Hathaway's massive writedown on Kraft Heinz signals a fundamental shift in the food industry. Legacy brands are struggling to adapt to modern consumer preferences, creating opportunities for innovative companies that prioritise plant-based, organic, and healthier alternatives. This transformation represents a powerful long-term trend that savvy investors can capitalise on.
What You Need to Know
This group focuses on companies disrupting the traditional food value chain through natural ingredients, healthier products, and modern distribution methods. These businesses are capturing market share from established giants by meeting consumer demands that legacy brands have failed to address. The theme represents exposure to evolving dietary habits and changing food preferences.
Why These Stocks
Each company was handpicked by professional analysts for its ability to benefit from the decline of traditional packaged food brands. These firms are positioned to capture growth as consumers abandon old favourites in favour of healthier, more natural options. They represent tactical plays on a consumer trend that's reshaping the entire food industry.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+62.86%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 62.86% over the next year.
Stocks Rated Buy by Analysts
13 of 16 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
The Plant-Based Revolution
Consumer demand for plant-based alternatives is exploding as people prioritise health and sustainability. These companies are at the forefront of this massive dietary shift that's reshaping entire food categories.
Legacy Brands Are Struggling
Warren Buffett's massive Kraft Heinz writedown proves that even the smartest investors can get caught off guard by changing consumer tastes. This creates opportunities for nimble competitors to steal market share.
First-Mover Advantage
These innovative food companies are capturing market share whilst legacy brands struggle to adapt. Getting in early on this trend could position you ahead of the curve as the food industry transforms.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Unlock all the stocks in this group on Nemo
Sign up free to view all stocks in this group and never miss out on another investment opportunity with Nemo.
Sign up in 60 seconds
Zero commission trading
SIPC-protected up to $500,000
Backed by Exinity Group
6% AER interest on uninvested cash, paid out daily
AI investment insights
Discover More Opportunities
Powering The Cloud: The AWS Build-Out
Amazon's recent earnings beat was powered by strong growth in its cloud computing division, AWS, prompting a $100 billion investment in AI and cloud infrastructure. This move signals a major opportunity for companies that provide the essential hardware and software for building out the next generation of data centers.
The Pentagon's Software Pivot
The U.S. Army's $10 billion enterprise agreement with Palantir signals a major shift in defense procurement toward consolidated software contracts. This new model creates opportunities for other large technology firms capable of providing streamlined, large-scale IT and AI solutions to the military.
Navigating Pharma Price Controls
President Trump's ultimatum to major pharmaceutical firms to lower drug prices creates significant market uncertainty for brand-name drug makers. This situation could benefit companies that thrive on reducing healthcare costs, such as generic drug manufacturers and prescription discount platforms.
Frequently Asked Questions
Everything you need to know about the product and billing.